Ferrous sulfate-directed dual-cross-linked hyaluronic acid hydrogels with long-term delivery of donepezil.
Animals
Cross-Linking Reagents
/ chemistry
Delayed-Action Preparations
Donepezil
/ administration & dosage
Dopamine
/ chemistry
Drug Carriers
Drug Compounding
Drug Liberation
Ferrous Compounds
/ chemistry
Hardness
Hyaluronic Acid
/ chemistry
Hydrogels
Injections, Subcutaneous
Male
Polylactic Acid-Polyglycolic Acid Copolymer
/ chemistry
Rats, Sprague-Dawley
Coordination
Covalent bonding
Donepezil
Ferrous sulfate
Hyaluronic acid
Hydrogel
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
30 May 2020
30 May 2020
Historique:
received:
17
01
2020
revised:
19
03
2020
accepted:
04
04
2020
pubmed:
12
4
2020
medline:
20
2
2021
entrez:
12
4
2020
Statut:
ppublish
Résumé
Ferrous sulfate (FeSO
Identifiants
pubmed: 32278055
pii: S0378-5173(20)30293-3
doi: 10.1016/j.ijpharm.2020.119309
pii:
doi:
Substances chimiques
Cross-Linking Reagents
0
Delayed-Action Preparations
0
Drug Carriers
0
Ferrous Compounds
0
Hydrogels
0
Polylactic Acid-Polyglycolic Acid Copolymer
1SIA8062RS
ferrous sulfate
39R4TAN1VT
Donepezil
8SSC91326P
Hyaluronic Acid
9004-61-9
Dopamine
VTD58H1Z2X
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119309Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.